Skip to main content
. 2012 Nov 7;7(11):e48184. doi: 10.1371/journal.pone.0048184

Figure 4. Figure 4a: Key features of Latent Class Model A, mortality trends, and response to bucindolol.

Figure 4

Figure 4b: Key features of Latent Class Model B, mortality trends, and response to bucindolol.